Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 38

1.

Evidence, interpretation, and qualification from multiple reports of long-term outcomes in the Multimodal Treatment Study of children with ADHD (MTA): Part II: supporting details.

Swanson J, Arnold LE, Kraemer H, Hechtman L, Molina B, Hinshaw S, Vitiello B, Jensen P, Steinhoff K, Lerner M, Greenhill L, Abikoff H, Wells K, Epstein J, Elliott G, Newcorn J, Hoza B, Wigal T; MTA Cooperative Group..

J Atten Disord. 2008 Jul;12(1):15-43. doi: 10.1177/1087054708319525.

PMID:
18573924
2.

Evidence, interpretation, and qualification from multiple reports of long-term outcomes in the Multimodal Treatment study of Children With ADHD (MTA): part I: executive summary.

Swanson J, Arnold LE, Kraemer H, Hechtman L, Molina B, Hinshaw S, Vitiello B, Jensen P, Steinhoff K, Lerner M, Greenhill L, Abikoff H, Wells K, Epstein J, Elliott G, Newcorn J, Hoza B, Wigal T; MTA Cooperative Group..

J Atten Disord. 2008 Jul;12(1):4-14. doi: 10.1177/1087054708319345.

PMID:
18573923
3.
4.

What does the MTA study tell us about effective psychosocial treatment for ADHD?

Greene RW, Ablon JS.

J Clin Child Psychol. 2001 Mar;30(1):114-21. Review.

PMID:
11294069
5.

Treatment of attention-deficit/hyperactivity disorder: overview of the evidence.

Brown RT, Amler RW, Freeman WS, Perrin JM, Stein MT, Feldman HM, Pierce K, Wolraich ML; American Academy of Pediatrics Committee on Quality Improvement.; American Academy of Pediatrics Subcommittee on Attention-Deficit/Hyperactivity Disorder..

Pediatrics. 2005 Jun;115(6):e749-57. Review.

PMID:
15930203
6.

Diagnosis and treatment of attention deficit hyperactivity disorder (ADHD).

[No authors listed]

NIH Consens Statement. 1998 Nov 16-18;16(2):1-37. Review.

PMID:
10868163
7.

Commentary on the multimodal treatment study of children with ADHD.

Barkley RA.

J Abnorm Child Psychol. 2000 Dec;28(6):595-9. Review.

PMID:
11104320
8.
9.

Efficacy and safety limitations of attention-deficit hyperactivity disorder pharmacotherapy in children and adults.

Wigal SB.

CNS Drugs. 2009;23 Suppl 1:21-31. doi: 10.2165/00023210-200923000-00004. Review.

PMID:
19621975
10.

[Evidence based therapy of children and adolescents with attention deficit/hyperactivity hyperkinetic syndrome (ADHS)].

Döpfner M, Lehmkuhl G.

Prax Kinderpsychol Kinderpsychiatr. 2002 Jul-Aug;51(6):419-40. Review. German.

PMID:
12235708
11.

A clinical review of outcomes of the multimodal treatment study of children with attention-deficit/hyperactivity disorder (MTA).

Murray DW, Arnold LE, Swanson J, Wells K, Burns K, Jensen P, Hechtman L, Paykina N, Legato L, Strauss T.

Curr Psychiatry Rep. 2008 Oct;10(5):424-31. Review.

PMID:
18803917
12.

Treatment of Attention-Deficit/Hyperactivity Disorder in Adolescents: A Systematic Review.

Chan E, Fogler JM, Hammerness PG.

JAMA. 2016 May 10;315(18):1997-2008. doi: 10.1001/jama.2016.5453. Review.

PMID:
27163988
13.

Multimodal treatments for childhood attention-deficit/hyperactivity disorder: interpreting outcomes in the context of study designs.

Hoza B, Kaiser NM, Hurt E.

Clin Child Fam Psychol Rev. 2007 Dec;10(4):318-34. Review.

PMID:
17710545
14.

Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD).

Storebø OJ, Ramstad E, Krogh HB, Nilausen TD, Skoog M, Holmskov M, Rosendal S, Groth C, Magnusson FL, Moreira-Maia CR, Gillies D, Buch Rasmussen K, Gauci D, Zwi M, Kirubakaran R, Forsbøl B, Simonsen E, Gluud C.

Cochrane Database Syst Rev. 2015 Nov 25;(11):CD009885. doi: 10.1002/14651858.CD009885.pub2. Review.

15.
16.

Tricyclic antidepressants for attention deficit hyperactivity disorder (ADHD) in children and adolescents.

Otasowie J, Castells X, Ehimare UP, Smith CH.

Cochrane Database Syst Rev. 2014 Sep 19;(9):CD006997. doi: 10.1002/14651858.CD006997.pub2. Review.

PMID:
25238582
17.
18.
19.

Cost effectiveness of pharmacotherapies for attention-deficit hyperactivity disorder: a systematic literature review.

Wu EQ, Hodgkins P, Ben-Hamadi R, Setyawan J, Xie J, Sikirica V, Du EX, Yan SY, Erder MH.

CNS Drugs. 2012 Jul 1;26(7):581-600. doi: 10.2165/11633900-000000000-00000. Review.

PMID:
22712698
20.

Attention-deficit/hyperactivity disorder.

Shaywitz BA, Fletcher JM, Shaywitz SE.

Adv Pediatr. 1997;44:331-67. Review.

PMID:
9265975
Items per page

Supplemental Content

Support Center